Loading...


*  Bay K 8644 | L-type Ca|sup|2+|/sup| channel agonist | Hello Bio
... channel agonist from Hello Bio, a trusted supplier for life science researchers worldwide ... a calcium channel agonist, in alveolar type II cells.. Sen N et al (1997) Biochem Pharmacol 53(9) : 1307-13. PubMedID: 9214691 ... Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice.. Shin EJ et al (2004) Behav ... L-type Ca2+ channel agonist. Causes reduced inotropy in the myocardium. Also aids induced pluripotent stem cell generation from ...
  https://www.hellobio.com/bay-k-8644.html
*  6-Iodoresiniferatoxin | TRPV1 channel agonist | Hello Bio
... high quality TRPV1 channel agonist from Hello Bio, a trusted supplier for life science researchers worldwide ... TRPV1 receptor partial agonist (Ki = 0.71 nM for hVR1). Full agonist at rat VR1. ... Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human vanilloid VR1 ...
  https://www.hellobio.com/6iodoresiniferatoxin.html
*  BAYK 8644 | CAS#71145-03-4 |Ca2+ channel activator | MedKoo
BAYK 8644 is a L-type Ca2+ channel activator (EC50 = 17.3 nM). BAYK 8644 has positive inotropic, vasoconstrictive and ... Effects of a calcium-channel agonist BayK 8644. Pflugers Arch. 2007 Jul;454(4):605-14. PubMed PMID: 17333247. ... 3: Turner CP, Debenedetto D, Liu C. NMDAR blockade-induced neonatal brain injury: Reversal by the calcium channel agonist BayK ... 11: Fredholm BB, Hu PS, Lindgren E. The dihydropyridine calcium-channel agonist BayK 8644 inhibits the presynaptic effects of R ...
  http://www.medkoo.com/products/12395
*  Characterizing the efficacy of calcium channel agonist-release strategies for bone tissue engineering applications. - Nuffield...
Bay was released continually from scaffolds within the physiological range required for agonist activity (1-10 microM). Patch ... Calcium Channel Agonists, Calcium Channels, L-Type, Cell Line, Tumor, Delayed-Action Preparations, Drug Stability, Lactic Acid ... Characterizing the efficacy of calcium channel agonist-release strategies for bone tissue engineering applications. ... Characterizing the efficacy of calcium channel agonist-release strategies for bone tissue engineering applications. ...
  https://www.ndcn.ox.ac.uk/publications/605610
*  Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle...
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ... Known or suspected disorders of calcium metabolism associated with hypercalcaemia. *Known or suspected severe renal ...
  https://clinicaltrials.gov/show/NCT00670241
*  A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ... Subjects with known/suspected disorders of calcium metabolism associated with hypercalcemia within the last 10 years, based on ...
  https://clinicaltrials.gov/ct2/show/NCT01580488
*  Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis - Full Text View -...
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ...
  https://clinicaltrials.gov/ct2/show/NCT00004402
*  Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ... previous/current calcium metabolic disease, taking calcium-lowering therapy or medication known to affect systemic calcium ... Patients with hypercalcemia (ionised serum calcium , 1.35 mmol/l or albumin corrected serum calcium , 2.68 mmol/l), ...
  https://clinicaltrials.gov/show/NCT00051545
*  A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) - Full Text View -...
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ...
  https://clinicaltrials.gov/show/NCT02416258
*  Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy - Full Text...
Calcium Channel Agonists. Membrane Transport Modulators. Vasoconstrictor Agents. Vitamins. To Top. *For Patients and Families ... effects of calcitriol +/- dexamethasone on serum PTH, urinary calcium and MAPK activity and VDR expression in serum, urine and ...
  https://clinicaltrials.gov/ct2/show/NCT00010231
*  Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ... Experimental: Calcitriol & Calcium All patients received twice daily Calcitriol and Calcium 1000mg divided into four doses ... This side effect usually occurs even while maintaining the serum calcium in the normal range and may lead to calcium deposition ... Drug: Calcitriol & Calcium Twice daily oral calcitriol with 1000 mg Calcium carbonate supplementation ...
  https://clinicaltrials.gov/show/NCT00001304
*  hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ... calcium [ Time Frame: 2 weeks ]. *phosphorus [ Time Frame: 2 weeks ]. *Parathyroid hormone [ Time Frame: 2 weeks ]. *T-cell ...
  https://clinicaltrials.gov/ct2/show/NCT01026363?recr=Open&cond=%22Renal+Insufficiency%2C+Chronic%22&rank=19
*  A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of...
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ... abnormal serum calcium or phosphate, and/or active renal stone disease when a calcium supplement is contraindicated ... Drug: alendronate 70-mg/vitamin D3 5600 IU combination tablet (Fosamax Plus) Drug: Calcitriol Dietary Supplement: Calcium 500 ... current use of calcium supplement in amount excess of 1500 mg daily, unless willing to discontinue this dose during the study, ...
  https://clinicaltrials.gov/show/NCT01350934
*  Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia - Full Text View - ClinicalTrials...
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ...
  https://clinicaltrials.gov/show/NCT00118066
*  Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease...
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ...
  https://clinicaltrials.gov/ct2/show/NCT01561222
*  Calcitriol in Advanced Intrahepatic Cholangiocarcinoma - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Vasoconstrictor Agents. To Top. *For Patients and Families ...
  https://clinicaltrials.gov/ct2/show/study/NCT01039181?view=record
*  DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing...
Calcium Channel Agonists. Membrane Transport Modulators. Vasoconstrictor Agents. Vitamins. Micronutrients. Growth Substances. ...
  https://clinicaltrials.gov/ct/show/NCT00273338
*  'Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy' - Full Text View - ClinicalTrials...
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ...
  https://clinicaltrials.gov/ct2/show/NCT01694433
*  ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Vasoconstrictor Agents. Vitamins. Micronutrients. Growth Substances. ...
  https://clinicaltrials.gov/ct2/show/NCT00043576
*  Vitamin D and Arterial Function in Patients With Chronic Kidney Disease - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ...
  https://clinicaltrials.gov/ct2/show/NCT01384539
*  Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol - Full Text View - ClinicalTrials.gov
Calcium Metabolism Disorders. Water-Electrolyte Imbalance. Calcitriol. Ergocalciferols. Calcium Channel Agonists. Membrane ... These subjects must have a most recent calcium level within the normal range, most recent phosphorus level , 8 mg/dL and a most ... This agent is believed to have an effect more specific to the parathyroid gland, and less specific to absorption of calcium and ... Percentage of patients in range for calcium during the 3 months after randomization and 3 months after cross-over. [ Time Frame ...
  https://clinicaltrials.gov/ct2/show/NCT01725113?recr=Open&cond=%22Hypercalcemia%22&rank=9
*  Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba - Full Text View -...
Calcium Channel Agonists. Membrane Transport Modulators. Vasoconstrictor Agents. Vitamins. Micronutrients. Growth Substances. ...
  https://clinicaltrials.gov/ct2/show/NCT01388517
*  Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ... In a review of the effects on calcium homeostasis, it was noted that calcipotriol (50 µg/g) had no effects on serum or urine ... However, patients had reduced levels of parathyroid hormone; mean serum and urine calcium were increased during treatment and ... Thus, while calcipotriol ointment was shown to be effective, the potential for alterations in calcium homeostasis have limited ...
  https://clinicaltrials.gov/ct2/show/NCT00625326
*  Paricalcitol Effect on Anemia in CKD - Full Text View - ClinicalTrials.gov
Calcium Channel Agonists. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasoconstrictor Agents ...
  https://clinicaltrials.gov/ct2/show/NCT01768351